Established Sekai Biotech Co., Ltd. to realize an AI-driven "Cell World Model."
May 25, 2026
We are pleased to announce that Sekai Biotech Co., Ltd. (Headquarters: Tokyo, Representative Director: Tofuku Kawakami) was established on May 25, 2026, with the aim of researching, developing, and socially implementing a "Cellular World Model." This model leverages AI technology that tightly integrates automated experimental systems, world models, and reinforcement learning, enabling the prediction and control of cellular states.
Background of establishment
In drug discovery and life science research, enormous experimentation and trial-and-error are required, and the development of new treatments takes a long time and considerable cost.
In recent years, the progress of generative AI and world models has greatly expanded the possibilities of AI in predicting and understanding the real world. On the other hand, in the field of life sciences, its potential has not been fully utilized due to challenges such as the complexity of biological data and integration with experimental systems.
Sekai Biotech aims to achieve a "Cellular World Model" that predicts and controls cellular state changes by building a unique AI platform that integrates automated experimental systems, reinforcement learning, and world models. Through closed-loop R&D that continuously cycles AI and experimentation, we are transforming the very nature of exploration in life sciences and working to accelerate and advance research and development.
Business activities
Our company promotes research and development in the following areas by leveraging cell world models.
- Development of a pathological assessment model
- Development of a toxicity evaluation model
- Building an AI Platform for Drug Discovery Research
- Cell State Prediction and Control Technology Research and Development
In the future, we aim to provide new AI infrastructure that supports the decision-making of researchers and companies in the fields of drug discovery, regenerative medicine, and biotechnology.
Company Profile
Company nameSekai Biotech Co., Ltd.
EstablishmentMay 25, 2026
RepresentativeRepresentative Director, Toyofuku Kawakami
Business activitiesDevelopment of Pathological and Toxicological Evaluation Models Utilizing Cell World Models